Is this email not displaying correctly? View it in your browser 

ADVERTISEMENT

2023 Biomarkers Congress_728 x 90  
NCCN-Ebulletin-Headers
       April 24, 2023

Pharmacy-Updates-Ads-2022-460x212

NCCN 2023 Pharmacy Updates: A Webinar Series

Upcoming pharmacy update webinars will focus on changing treatment paradigms in chronic lymphocytic leukemia, the role of PD-L1 therapy in early treatment of triple negative breast cancer, and more. Learn more

NCCN Global Policy Webinar

Join us virtually on June 29 to learn about the utility and value of National Cancer Control Plans (NCCPs) across the economic spectrum. Register now

NCCN Publishes New Resource to Help Patients Understand Quick-Moving Type of Breast Cancer

NCCN published NCCN Guidelines for Patients®: Inflammatory Breast Cancer explaining how this particular disease type and its treatment approaches are different from more common forms of breast cancer. Learn more

June 2023 Summit Web Ads_460 x 212

Live Events

In two weeks!
NCCN 2023 Congress: Biomarkers in Solid Tumors
  

Virtual Attendance | May 12, 2023

Register

NCCN Oncology Policy Summit: Cancer Across Geography 

Washington, D.C. and Virtual Attendance | 
June 15, 2023

Register
NCCN Global Policy Webinar: The Utility and Value of National Cancer Control Plans (NCCPs) Across the Economic Spectrum
Virtual Attendance | June 29, 202
 Register

Clinical Webinars (CE/CME)

Monthly Oncology Tumor Boards: Neoadjuvant and Adjuvant Therapy for Patients with Resectable Early-Stage and Locally Advanced Non-Small Cell Lung Cancer

May 16, 2023
Register

NCCN Pharmacy Updates™: Changing Treatment Paradigms in Chronic Lymphocytic Leukemia 

May 24, 2023 

Register

NCCN Pharmacy Updates™: The Role of PD-L1 Therapy in the Early Treatment of Triple Negative Breast Cancer

May 31, 2023

Register 
 

Patient Webinars

Next week!

CAR T-Cell Therapy for Lymphoma and Side Effects

May 3, 2023

Register

NCCN Guidelines® Updates

NCCN Flash Updates: NCCN Templates Updated for Breast Cancer (April 17, 2023)

 View

 

NCCN in the News

Targeted Oncology: NCCN Considers Changing Neoadjuvant Landscape in Rectal Cancer (April 18, 2023)Read More
 

AJMC: Conversations on Equity in Cancer Care: Meet the Leaders of NCCN’s DEI Directors Forum (April 17, 2023)
Read More
 

Healthline: Breast Cancer: How Depression Can Affect the Likelihood of Survival 
(April 17, 2023)

Read More
 

CBS News: Woman Stresses Importance of Advocating for Your Health After Cancer Fight (April 17, 2023)
Read More
 

News from NCCN Member Institutions

New Study Flips the Script on Liver Cancer (UC San Diego Moores Cancer Center)
Read More
 

Tiny DNA Circles Are Key Drivers Of Cancer, Stanford Medicine-Led International Study Finds (Stanford Cancer Institute)
Read More  

MD Anderson Research Highlights AACR 2023 Special Edition 
(The University of Texas MD Anderson Cancer Center)
Read More
 

Clinical Trial Improves Neurocognitive Outcomes For Childhood Craniopharyngioma
(St. Jude Children's Research Hospital)
Read More
 

ADVERTISEMENT
Webinar-Ads_468 x 60

About NCCN > NCCN Annual Report > NCCN Guidelines® > NCCN Store
> Patient Resources  > Event Calendar JNCCN > Online Catalog


Follow Us

Facebook Twitter LinkedIn Instagram


ADVERTISEMENT
AdvertisementMerck, Keytruda
 
ADVERTISEMENT
160 x 600-pocketguide
 
ADVERTISEMENT
ORP-Opps-Web-ads-160x600
Forward to a Friend

Search past NCCN eBulletins

EB-N-0767-0423

If you would like to subscribe to NCCN eBulletin and receive other information from NCCN, click here to register.

If you would like to update your e-mail preferences, click here to update or opt-out.

National Comprehensive Cancer Network | 3025 Chemical Road, Suite 100 | Plymouth Meeting | PA | 19462 | US | 215.690.0300


Cvent - Web-based Software Solutions